1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–503. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Trabelsi S, Brahim DH, Ladib M, Mama N,
Harrabi I, Tlili K, Yacoubi MT, Krifa H, Hmissa S, Saad A and Mokni
M: Glioma epidemiology in the central tunisian population:
1993–2012. Asian Pac J Cancer Prev. 15:8753–8757. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Wrensch M, Fisher JL, Schwartzbaum JA,
Bondy M, Berger M and Aldape KD: The molecular epidemiology of
gliomas in adults. Neurosurg Focus. 19:E52005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Reich DE, Cargill M, Bolk S, Ireland J,
Sabeti PC, Richter DJ, Lavery T, Kouyoumjian R, Farhadian SF, Ward
R and Lander ES: Linkage disequilibrium in the human genome.
Nature. 411:199–204. 2001. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Lander ES: Initial impact of the
sequencing of the human genome. Nature. 470:187–197. 2011.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Monnier P, Martinet C, Pontis J, Stancheva
I, Ait-Si-Ali S and Dandolo L: H19 lncRNA controls gene expression
of the Imprinted Gene Network by recruiting MBD1. Proc Natl Acad
Sci U S A. 110:20693–20698. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Lee JT: Epigenetic regulation by long
noncoding RNAs. Science. 338:1435–1439. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhou M, Wang X, Shi H, Cheng L, Wang Z,
Zhao H, Yang L and Sun J: Characterization of long non-coding
RNA-associated ceRNA network to reveal potential prognostic lncRNA
biomarkers in human ovarian cancer. Oncotarget. 7:12598–12611.
2016.PubMed/NCBI
|
12
|
Feng W, Li L, Xu X, Jiao Y and Du W:
Up-regulation of the long non-coding RNA RMRP contributes to glioma
progression and promotes glioma cell proliferation and invasion.
Arch Med Sci. 13:1315–1321. 2017. View Article : Google Scholar : PubMed/NCBI
|
13
|
Wang XP, Shan C, Deng XL, Li LY and Ma W:
Long non-coding RNA PAR5 inhibits the proliferation and progression
of glioma through interaction with EZH2. Oncol Rep. 38:3177–3186.
2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ma Y, Zhou G, Li M, Hu D, Zhang L, Liu P
and Lin K: Long noncoding RNA DANCR mediates cisplatin resistance
in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling
pathway. Neurochem Int. 118:233–241. 2018. View Article : Google Scholar : PubMed/NCBI
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Alonso MM, Diez-Valle R, Manterola L,
Rubio A, Liu D, Cortes-Santiago N, Urquiza L, Jauregi P, Lopez de
Munain A, Sampron N, et al: Genetic and epigenetic modifications of
Sox2 contribute to the invasive phenotype of malignant gliomas.
PLoS One. 6:e267402011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Chen X, Dai M, Zhu H, Li J, Huang Z, Liu
X, Huang Y, Chen J and Dai S: Evaluation on the diagnostic and
prognostic values of long non-coding RNA BLACAT1 in common types of
human cancer. Mol Cancer. 16:1602017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Shan D, Shang Y and Hu T: Long noncoding
RNA BLACAT1 promotes cell proliferation and invasion in human
cervical cancer. Oncol Lett. 15:3490–3495. 2018.PubMed/NCBI
|
19
|
Ye JR, Liu L and Zheng F: Long noncoding
RNA bladder cancer associated transcript 1 promotes the
proliferation, migration, and invasion of nonsmall cell lung cancer
through sponging miR-144. DNA Cell Biol. 36:845–852. 2017.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Wu X, Zheng Y, Han B and Dong X: Long
noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin
resistance of gastric cancer via sponging miR-361. Biomed
Pharmacother. 99:832–838. 2018. View Article : Google Scholar : PubMed/NCBI
|
21
|
Liao D, Lv G, Wang T, Min J, Wang Y and
Liu S: Prognostic value of long non-coding RNA BLACAT1 in patients
with papillary thyroid carcinoma. Cancer Cell Int. 18:472018.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Li Y, Huang S, Li Y, Zhang W, He K, Zhao
M, Lin H, Li D, Zhang H, Zheng Z and Huang C: Decreased expression
of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and
EMT in colorectal cancer cells. Tumor Biol. 37:14205–14215. 2016.
View Article : Google Scholar
|
24
|
He R, Zhang FH and Shen N: LncRNA
FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through
suppressing E-cadherin and regulating WNT pathway in non-small cell
lung cancer (NSCLC). Biomed Pharmacother. 95:331–338. 2017.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic modalities. Cell.
169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
26
|
Tian L, Zhao Z, Xie L and Zhu J:
MiR-361-5p inhibits the mobility of gastric cancer cells through
suppressing epithelial-mesenchymal transition via the Wnt/β-catenin
pathway. Gene. 675:102–109. 2018. View Article : Google Scholar : PubMed/NCBI
|
27
|
Yuan H, Wei R, Xiao Y, Song Y, Wang J, Yu
H, Fang T, Xu W and Mao S: RHBDF1 regulates APC-mediated
stimulation of the epithelial-to-mesenchymal transition and
proliferation of colorectal cancer cells in part via the
Wnt/β-catenin signalling pathway. Exp Cell Res. 368:24–36. 2018.
View Article : Google Scholar : PubMed/NCBI
|